摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S)-5-(二氨基亚甲基氨基)-2-[(4-甲基苯基)磺酰基氨基]-N-(4-硝基苯基)戊酰胺 | 36186-55-7

中文名称
(2S)-5-(二氨基亚甲基氨基)-2-[(4-甲基苯基)磺酰基氨基]-N-(4-硝基苯基)戊酰胺
中文别名
——
英文名称
N(alpha)-Tosylarginine-4-nitroanilide
英文别名
(2S)-5-(diaminomethylideneamino)-2-[(4-methylphenyl)sulfonylamino]-N-(4-nitrophenyl)pentanamide
(2S)-5-(二氨基亚甲基氨基)-2-[(4-甲基苯基)磺酰基氨基]-N-(4-硝基苯基)戊酰胺化学式
CAS
36186-55-7
化学式
C19H24N6O5S
mdl
——
分子量
448.5
InChiKey
PSEZMMMPQYFCHI-KRWDZBQOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    31
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    194
  • 氢给体数:
    4
  • 氢受体数:
    7

文献信息

  • Process for producing arginyl-p-nitroanilide
    申请人:NITTO BOSEKI CO., LTD.
    公开号:EP0137742A1
    公开(公告)日:1985-04-17
    An Nα-protected-NG-protected-arginyl-p-nitroanilide with high purity can be produced in high yield by reacting an Nα-protected-NG-protected-arginine with p-nitroaniline in pyridine in the presence of a condensing agent.
    在有缩合剂存在的情况下,将 Nα-保护-NG-保护-精酸与对硝基苯胺吡啶中进行反应,可以高产率地生产出高纯度的 Nα-保护-NG-保护-精酰-对硝基苯胺
  • Substrates for determination of enzyme activity
    申请人:NITTO BOSEKI CO., LTD.
    公开号:EP0350915A2
    公开(公告)日:1990-01-17
    Compounds represented by the following formula: wherein A1 and A2 each represents a specific amino acid residue, are excellent as substrates for determination of enzyme activity such as trypsin, etc.
    下式所代表的化合物 其中 A1 和 A2 各代表一个特定的氨基酸残基,是测定胰蛋白酶等酶活性的极佳底物。
  • Assay, employing analog to digital signaling, for the presence of an analyte in a sample in conjunction with a binding component, apparatus for performing said process, and a method of performing said assay
    申请人:ENZYMATICS, INC.
    公开号:EP0494509A1
    公开(公告)日:1992-07-15
    An assay, method of performing said assay, and apparatus, capable of generating an "on"/"off" response from a changing concentration of sample analyte, are described. The assay system comprises a high affinity binding component for a sample analyte and has an analyte dissociation constant substantially less than the concentration of analyte to be measured. Under initial conditions, wherein there is an absence of added analyte, a substantial number of binding sites must be empty. The concentration of empty binding sites determines the threshold analyte concentration, or "trigger point," for the "on"/"off" switch. Also required are a means for determining when excess analyte is present after the binding sites are substantially completely filled, wherein said means has an affinity for analyte which is substantially less than the binding component affinity for analyte. Also described is a diagnostic apparatus, comprising a set of compartments, each with a different threshold analyte concentration. A signal is generated in each compartment only when the analyte concentration is greater than the preset threshold, allowing instrument-independent, accurate measurement of analyte concentration.
    本文描述了一种能够根据样品分析物浓度的变化产生 "开"/"关 "响应的检测方法、执行所述检测的方法和仪器。该检测系统包括一个与样品分析物高亲和力结合的组件,其分析物解离常数大大小于待测分析物的浓度。在没有添加分析物的初始条件下,大量的结合位点必须是空的。空结合位点的浓度决定了 "开"/"关 "开关的阈值分析物浓度或 "触发点"。还需要一种方法,用于在结合位点基本完全填满后确定何时存在过量的分析物,其中所述方法对分析物的亲和力大大低于结合元件对分析物的亲和力。 还描述了一种诊断设备,包括一组隔室,每个隔室都有不同的分析物阈值浓度。只有当被分析物浓度大于预设阈值时,才会在每个隔室中产生信号,从而实现与仪器无关的、精确的被分析物浓度测量。
  • Substrates for determination of enzyme activity and intermediates for synthesis of the substrates as well as process for producing the intermediates
    申请人:NITTO BOSEKI CO., LTD.
    公开号:EP0513863A1
    公开(公告)日:1992-11-19
    Novel compounds represented by the following formula: wherein A and B each represents a specific amino acid residue are excellent as substrates for determination of enzyme activity such as trypsin, etc. The compounds can be synthesized from novel arginyl-3-tert-alkyloxycarbonyl-4-nitroanilides.
    下式所代表的新型化合物: 其中 A 和 B 各代表一个特定的氨基酸残基,是测定胰蛋白酶等酶活性的极佳底物。这些化合物可由新型精酰-3-叔烷氧基羰基-4-硝基苯胺合成。
  • US4564695A
    申请人:——
    公开号:US4564695A
    公开(公告)日:1986-01-14
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸